The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics
Authors:
- 1 January 2013
- journal article
- research article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 118, 94-99
Abstract
No abstract availableKeywords
Funding Information
- École Polytechnique Fédérale de Lausanne
- Rijksuniversiteit Groningen
- Beneficentia Stiftung
This publication has 50 references indexed in Scilit:
- Novel roles of peroxiredoxins in inflammation, cancer and innate immunityJournal of Clinical Biochemistry and Nutrition, 2012
- Concurrent genetic alterations in DNA polymerase proofreading and mismatch repair in human colorectal cancerEuropean Journal of Human Genetics, 2010
- Pro-cathepsin D interacts with the extracellular domain of the β chain of LRP1 and promotes LRP1-dependent fibroblast outgrowthJournal of Cell Science, 2010
- Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancerBritish Journal of Cancer, 2010
- Identification of the putative tumor suppressor Nit2 as ω-amidase, an enzyme metabolically linked to glutamine and asparagine transaminationBiochimie, 2009
- Cathepsin D—Many functions of one aspartic proteaseCritical Reviews in Oncology/Hematology, 2008
- Proteomic Approaches in Understanding Action Mechanisms of Metal-Based Anticancer DrugsMetal-Based Drugs, 2008
- Systems biology in drug discoveryNature Biotechnology, 2004
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976